baber/WOPTO huggingface dataset:
Patent ES-2123669-T3 (ES)
Inventor: GILBERT RICHARD JAMES
IPC: C07K7/06
Filed: 1993-10-28
Granted: 1999-01-16
Abstract: A plasminogen analogue activatable by thrombin to have plasmin activity which contains the cleavage site sequence P4-P3-Pro-Arg-P1'-P2' where P3 is a basic amino acid residue, P4 is a hydrophobic amino acid residue and each of P1' and P2' is independently a non-acidic amino acid residue, said site being cleavable by thrombin between Arg and P1'.
Patent ES-2103531-T3 (ES)
Inventor: VESTMAN RUNE G DIPL-ING
IPC: B41F35/00
Filed: 1994-11-10
Granted: 1997-09-16
Abstract: A method for fully automatic cylinder cleaning in printing machines which are equipped with a central control system and automated washing devices, having an extension of the central control system, by means of which the operating parameters are recorded to determine the respectively optimum washing sequence programmes for each individual washing device by access to the central printing-machine control system, the respectively optimum washing sequence programmes for each individual washing device are determined automatically, and the individual washing devices are controlled by the respectively corresponding optimum washing sequence programme.
Patent ES-2107750-T3 (ES)
Inventor: DE BOCK JAN JULIEN IRMA
IPC: G03G15/23
Filed: 1994-06-13
Granted: 1997-12-01
Abstract: An electrostatographic single-pass multiple station multi-colour printer for forming an image onto a web (12), eg of paper, is described. The printer comprises a plurality of toner image-producing electrostatographic printing stations (A, B, C, D, E) each having rotatable endless surface means (26) such as the photoconductive surface of a cylindrical drum (24) onto which a toner image can be formed. The paper web (12) is conveyed in succession past the printing stations (A, B, C, D, E). The speed and tension of the web (12) is controlled while it is running past the printing stations (A, B, C, D, E). Guiding rollers (36) which determine for the web (12) wrapping angles ( omega ) of about 15 DEG  about the drum surface. A corona device transfers the toner image on each drum onto the web (12). The corona device, the wrapping angles  omega  and the web tension are such that adherent contact of the web (12) with the drum surface (26) is such that the moving paper web (12) controls the peripheral speed of the drum in synchronism with the movement of said web. Slippage between the drum surface (26) and the paper web (12) is thereby eliminated, enabling accurate registration of superimposed images on the paper web (12). <IMAGE>
Patent ES-2124868-T3 (ES)
Inventor: CHUNG DAVID YEN-LUNG
IPC: C10M143/04
Filed: 1993-12-03
Granted: 1999-02-16
Abstract: The present invention relates to novel multifunctional viscosity modifiers comprising a mixture of derivatized ethylene-alpha olefin copolymers, A and B. Said A copolymer comprising from about 30 to about 60 weight percent monomer units derived from ethylene and said B copolymer comprising from about 60 to about 80 weight percent units derived from ethylene.
Patent ES-2111912-T3 (ES)
Inventor: BAKX MARTINUS
IPC: B65D71/12
Filed: 1993-11-22
Granted: 1998-03-16
Abstract: A keel structure in a wraparound carton comprises a number of keel elements (K) which separate one row of containers from another row within the carton. Each keel element has spaced upstanding panels (P, 32; Pa, 32a) against which containers held in the carton abut. Each of the upstanding panels is spaced from the other by a platform (P1, P1a) defined by curved edges (C, C1; Ca, C1a) extending towards one another permitting adjacent portions of each of said upstanding panel means to be flexed inwardly toward the other to receive a wall portion of an adjacent container.
Patent ES-2219647-T3 (ES)
Inventor: ALLEN ALLEN D
IPC: A61K38/00
Filed: 1994-03-21
Granted: 2004-12-01
Abstract: A method for treating and inhibiting disease associated with the human immunodeficiency virus (HIV) is provided. The method includes transforming the human immunodeficiency virus (HIV) infection into a nonserious disease through the infusion of monoclonal antibodies directed against particular antigens on anti-self, anti-CD4 cytotoxic T-lymphocytes.
Patent ES-2124408-T3 (ES)
Inventor: GRIESINGER RALPH-EDGAR
IPC: A01K63/04
Filed: 1994-05-06
Granted: 1999-02-01
Abstract: Described is a device for dissolving gases in liquids, in particular for the continuous upgrading of aquarium water with CO2 gas. The device consists of at least two chambers (1) disposed one above the other and open underneath, the chamber openings (2) facing downwards when the device is placed in its position of operation in order to provide well defined gas exchange surfaces (5) with the neighbouring liquid. Adjacent chambers (1) are disposed one above the other in such a way that, when the gas is passed into a lower chamber or the gas-feed chamber (18), the gas which overflows when this chamber is full is trapped in the chamber (1) immediately above it which acts an an air trap. The device is characterized in that at least two consecutive chambers (1) are integrated in a housing made up of two longitudinal elements (3, 4), each of which forms part of the wall of each chamber (1) integrated in the housing (6).
Patent ES-2098947-T3 (ES)
Inventor: BINET JEAN
IPC: A61P31/04
Filed: 1994-05-17
Granted: 1997-05-01
Abstract: PCT No. PCT/FR94/00584 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed May 17, 1994 PCT Pub. No. WO94/26713 PCT Pub. Date Nov. 24, 1994The present invention concerns  beta , beta -dimethyl-4-piperidineethanamine compounds of the formula:    <IMAGE>  (I)  (wherein groups R1 to R3 are defined as indicated in the description), and addition salts thereof. It also concerns a process for their preparation and their therapeutic use as inhibitors for the cholesterol biosynthesis, in particular as epoxysqualene cyclase inhibitors, for obtaining an as hypocholesterolemic, hypolipemic, antiatheromatic and/or antifungal drug.
Patent ES-2110764-T3 (ES)
Inventor: JALKANEN SIRPA
IPC: C12N15/02
Filed: 1994-06-16
Granted: 1998-02-16
Abstract: CD44 is a family of glycoproteins involved in cell-cell and cell-matrix interactions. In addition to the major 90 kD form present on most hematopoietic cells, larger forms are found on keratinocytes and carcinoma cell lines. These bigger isoforms of CD44 arise by alternative splicing that results in insertion of one or more of the "variant" exons into the extracellular part of the 90 kD constant form of the molecule. Antibodies were raised against a synthetic peptide containing a sequence encoded by the human exon 6A mAb thus obtained (designated Var3.1) strongly reacted with the plasma membranes of squamous cells in upper layers of skin and tonsil surface epithelia. Weaker staining was seen in germinal centers, vascular endothelia and enterocytes. CD44v6 was absent from tissue leukocytes and connective tissue components. In comparison, Hermes-3 epitope (on the constant part) containing forms of CD44 were preferentially localized in basal layers of epithelia, present on the surface of most leukocytes and connective tissue cells, and undetectable on the luminal surface of high endothelial venules. In benign neoplasms, epithelial cells stained with mAb Var3.1 like in normal tissues. In contrast, immunostaining of 30 squamous carcinoma specimens (both primary and metastatic lesions) revealed that malignant transformation resulted in down-regulation or disappearance of Var3.1 epitope, but in majority of cases, not in diminished expression of the Hermes-3 epitope. An examination of serum samples from normal individuals and from patients with inflammatory diseases indicated that CD44v6 was increased in samples from patients with rheumatoid arthritis or inflammatory bowel disease.
Patent ES-2117320-T3 (ES)
Inventor: SEDELMEYER BARBARA DR
IPC: B61L21/06
Filed: 1995-03-30
Granted: 1998-08-01
Abstract: The function monitoring device has a data processor (UE) receiving all the inputs for the schematic track display (ST), with storage of the switch conditions of the signalling image elements. A stored list of permissible logic rules is held in the data processor for comparison with the actual switch conditions, to provide an indication when a non-permissible switch condition is detected. The data processor checks the validity of the non-permissible switch condition and provides a warning signal only if the checked indication is consistent. <IMAGE>
Patent ES-2124476-T3 (ES)
Title: Caja de plastico con alojamiento amortiguador de las vibraciones de un elemento bondable.
Inventor: KUHNLE ANDREAS
IPC: H05K1/18
Filed: 1995-07-28
Granted: 1999-02-01
Abstract: SE DESCRIBE UNA CARCASA DE PLASTICO CON UN APOYO AMORTIGUADOR DE VIBRACION DE UN ELEMENTO (6) BONDERIZABLE, QUE ESTA UNIDO DE FORMA FIJA CON UN CUERPO (2) DE LA CARCASA (1) DE PLASTICO. ENTRE EL ELEMENTO (6) BONDERIZABLE Y EL CUERPO (2) DE LA CARCASA (1) DE PLASTICO SE INYECTA, SE DISPENSA O SE IMPRESIONA UN ELEMENTO (8A,8B) DE AMORTIGUACION A BASE DE MATERIAL ELASTICO.
Patent ES-2142449-T3 (ES)
Title: Elementos para formar paneles de oscurecimiento con pasos de aire y paneles de oscurecimiento obtenidos a partir de los mismos.
Inventor: GIGOLA ANTONIO
IPC: F24F13/08
Filed: 1995-10-03
Granted: 2000-04-16
Abstract: SE PRESENTA UN ELEMENTO MODULAR (1, 14, 18, 101, 201) PARA LA COMPOSICION DE PANELES DE OBSCURECIMIENTO CON CONDUCTOS PARA EL FLUJO DEL AIRE, EL ELEMENTO COMPRENDE UNA PLANCHA SUBSTANCIALMENTE PLANA (3, 103, 203); UNAS PRIMERAS ALETAS (5, 105, 205) QUE SOBRESALEN POR UN BORDE LIBRE DESDE AL MENOS UNA SUPERFICIE DE LA PLANCHA PARA DEFINIR CANALES ABIERTOS (2) ENTRE ELLAS Y CON LOS EXTREMOS OPUESTOS MIRANDO SOBRE BORDES LATERALES OPUESTOS DE LA PLANCHA (3, 103, 203); MEDIOS CONECTORES (4, 7, 104, 107, 204, 207) DISEÑADOS PARA PERMITIR EL MONTAJE DEL ELEMENTO (1, 14, 18, 101, 201) CON OTROS ELEMENTOS PARA FORMAR UN PANEL DE OBSCURECIMIENTO QUE TENGA SOBRE LAS CARAS OPUESTAS LAS PARTES OPUESTAS EXTREMAS DE LOS CANALES Y LAS PLANCHAS DE LOS ELEMENTOS DISPUESTAS EN EL SENTIDO DE CRUCE DE SU EXTENSION. UN PANEL SE OBTIENE MONTANDO UNA PLURALIDAD DE ELEMENTOS (1, 14, 18, 101, 201) ESTANDO DISPUESTOS LOS ELEMENTOS MUY CERCA EN UNA FILA DE MANERA QUE TENGAN LAS PLANCHAS (3, 103, 203) PARALELAS ENTRESI, CADA PLANCHA CONSTITUYE UN CERRAMIENTO PARA LOS CANALES (2) DE ELEMENTOS ADYACENTES PARA FORMAR CONDUCTOS (15) CON LOS EXTREMOS ABIERTOS EN LAS CARAS OPUESTAS DEL PANEL PARA EL PASO DEL AIRE ENTRE DICHAS CARAS OPUESTAS DEL PANEL.
Patent ES-2122472-T3 (ES)
Title: Derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
Inventor: AGOURIDAS CONSTANTIN
IPC: A61P31/04
Filed: 1995-05-02
Granted: 1998-12-16
Abstract: LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I) EN LAS QUE - R REPRESENTA UN RADICAL -(CH{SUB,2}){SUB,N}AR, - N REPRESENTA EL NUMERO 3,4 O 5 - AR REPRESENTA UN RADICAL HETEROCICLICO, EVENTUALMENTE SUSTITUIDO, - Z REPRESENTA UN ATOMO DE HIDROGENO O EL RESTO DE UN ACIDO. LOS COMPUESTOS DE FORMULA (I) PRESENTAN INTERESANTES PROPIEDADES ANTIBIOTICAS.
Patent ES-2117366-T3 (ES)
Title: Solera de hogar con lecho fluidificado.
Inventor: SURANITI SYLVESTRE
IPC: F27B15/02
Filed: 1995-06-09
Granted: 1998-08-01
Abstract: LA PRESENTE INVENCION SE REFIERE A UNA SOLERA DE HOGAR DE LECHO FLUIDO QUE COMPRENDE UNA CHAPA METALICA DE SOPORTE (1) ATRAVESADA POR BOQUILLAS (10) DE INYECCION DE GAS DE FLUIDIZACION Y PROVISTA POR UN REVESTIMIENTO DE MATERIAL REFRACTARIO. LA CHAPA DE SOPORTE (1) ES DE METAL REFRACTARIO Y EL REVESTIMIENTO ESTA CONSTITUIDO POR UNA PLURALIDAD DE ELEMENTOS PLANOS (6,6'') DE METAL REFRACTARIO QUE RECUBRE DICHA CHAPA DE SOPORTE (1), ESTANDO CADA ELEMENTO PLANO (6,6'') FIJADO A LA CHAPA DE SOPORTE (1) POR UNA SOLDADURA (8) EN UNA ZONA LOCALIZADA SENSIBLEMENTE PUNTUAL.
Patent ES-2131801-T3 (ES)
Title: Produccion de diciclopentadieno con calidad de polimerizacion.
Inventor: KEENAN MICHAEL JOHN
IPC: C07C2/50
Filed: 1994-12-08
Granted: 1999-08-01
Abstract: SE PRESENTA UN PROCESO PARA PURIFICAR DICICLOPENTADIENO CRUDO QUE COMPRENDE LOS PASOS DE: FRACTURAR EL DICICLOPENTADIENO CRUDO PARA FORMAR UN EFLUYENTE CON CONTENIDO MONOMERICO QUE COMPRENDE AL MENOS UN MONOMERO SELECCIONADO DE ENTRE EL GRUPO QUE CONSTA DE: DIENOS ACICLICOS C{SUB, 4}, DIENOS ACICLICOS C{SUB, 5}, CICLOPENTADIENO Y METILCICLOPENTADIENO; SEPARAR EL EFLUYENTE CON CONTENIDO MONOMERICO EN UNA CORRIENTE RICA CON CICLOPENTADIENO Y UNA CORRIENTE POBRE EN CICLOPENTADIENO; DIMERIZAR LA CORRIENTE RICA EN CICLOPENTADIENO PARA FORMAR UN EFLUYENTE DIMERIZADOR; LA PUESTA EN CONTACTO DE UN SEPARADOR DE MEMBRANA BAJO CONDICIONES DE PER-VAPORACION CON EL EFLUYENTE DIMERIZADOR EN EL QUE LOS DIENOS ACICLICOS C{SUB, 4}; LOS DIENOS ACICLICOS C{SUB, 5} Y EL CICLOPENTADIENO PENETRAN A TRAVES DEL SEPARADOR DE MEMBRANA Y EN DONDE EL PRODUCTO DE DICICLOPENTADIENO QUE TIENE UNA PUREZA DE AL MENOS UN 98% QUEDA RETENIDO. TAMBIEN SE PRESENTA UN APARATO PARA LLEVAR A CABO EL PROCESO.
Patent ES-2116747-T3 (ES)
Inventor: HILAIRE PIERRE
IPC: A61M25/00
Filed: 1995-04-12
Granted: 1998-07-16
Abstract: The present invention relates to a rapid-exchange dilatation catheter of the type comprising a flexible tubular body having a distal part, an intermediate part and a proximal part. According to the invention, the body comprises a core having a high modulus of elasticity, which core is permanently joined at one end to the proximal part and embedded at its other end in a wall defining an inner duct for a guide-wire to pass through. The invention finds a particular application in the treatment of stenoses of blood vessels.
Patent ES-2236707-T3 (ES)
Inventor: DAS GLADWIN S
IPC: A61F2/00
Filed: 1995-05-04
Granted: 2005-07-16
Abstract: A stent comprising a self-expandable cylindrical body constructed out a single integral piece of material, including a plurality of wavy closed windings and strips interconnecting the windings such that the stent is prevented from stretching longitudinally is provided. The stent is self-expandable from a first radially-constrained, unexpanded diameter to a second, radially-unconstrained, expanded diameter. The stent can be implanted within a body cavity of an animal to maintain patency thereof.
Patent ES-2133773-T3 (ES)
Title: Pelicula de modulo medio que comprende polietileno sustancialmente lineal y metodo de fabricacion.
Inventor: WOOSTER JEFFREY J
IPC: B29L7/00
Filed: 1995-05-09
Granted: 1999-09-16
Abstract: SE FABRICAN PELICULAS DE POLIETILENO DE MODULO MEDIO, CON RESISTENCIA MEJORADA AL DESGARRAMIENTO, PARA APLICACIONES DE EMBALAJE SUPERRESISTENTE, Y PARA LLENADO EN CALIENTE. LAS COMPOSICIONES DE PELICULA CONTIENEN POLIETILENO LINEAL DE ALTO PESO MOLECULAR, Y UN INTERPOLIMERO DE {AL}-OLEFINA/ETILENO SUSTANCIALMENTE LINEAL. LA PELICULA TIENE AL MENOS, APROXIMADAMENTE, 1.25 MILLONESIMAS DE PULGADA (31 MICRONES) DE GROSOR, UNA DENSIDAD DE PELICULA EN EL RANGO DE 0.293 A 0.95 GRAMOS/CENTIMETRO CUBICO (GR/CC), Y, TIPICAMENTE, PRESENTA UNA RESISTENCIA AL DESGARRAMIENTO, O RESISTENCIA AL IMPACTO, AL MENOS UN 30 POR CIENTO MAS ELEVADA QUE LA PELICULA DE POLIETILENO INDUSTRIAL ACTUAL. LA NUEVA PELICULA TIENE UNA BUENA ESTABILIDAD DIMENSIONAL, Y PROPIEDADES DE RESISTENCIA, LO CUAL PERMITE UNA REDUCCION APRECIABLE DEL CALIBRE.
Patent ES-2125650-T3 (ES)
Inventor: MUNDIGL JOSEF
IPC: G06K19/077
Filed: 1995-09-05
Granted: 1999-03-01
Abstract: A method for producing a smart card module includes bonding one end of a thin wire onto a first contact zone of a semiconductor chip. The wire is guided in a plurality of turns forming an antenna coil. The wire is bonded onto a second contact area of the semiconductor chip. The wire turns of the antenna coil and the semiconductor chip are placed on a carrier body.
Patent ES-2169159-T3 (ES)
Title: Montaje para tratar vasos sanguineos.
Inventor: KALMANN MENNO
IPC: A61B5/022
Filed: 1995-10-04
Granted: 2002-07-01
Abstract: LA INVENCION SE REFIERE A UNA CONEXION PARA EL TRATAMIENTO DE VASOS SANGUINEOS FORMADA POR UNA CAPA INTERNA ARTIFICIAL DE VASO SANGUINEO A MODO DE TUNICA INTIMA ARTIFICIAL O SIMILAR PARA SUSTITUIR UNA SECCION DE LA CAPA INTERNA DEL VASO SANGUINEO RETIRADA PREVIAMENTE DEL MISMO Y/O PARA CUBRIR UNA LONGITUD PREDETERMINADA DE LA CAPA INTERNA LESIONADA DEL VASO SANGUINEO, EN LA QUE DICHA CAPA INTERNA ARTIFICIAL SE ASOCIA CON EL VASO SANGUINEO EXISTENTE DE MODO QUE BASICAMENTE EVITA QUE LAS PARTES DESPRENDIDAS DEL VASO OBSTRUYAN LA CORRIENTE SANGUINEA QUE CIRCULA POR DICHO VASO; SE PRESENTAN LOS MEDIOS PARA INTRODUCIR LA CAPA INTERNA ARTIFICIAL EN EL VASO SANGUINEO.
Patent ES-2201132-T3 (ES)
Inventor: CHUDZIK STEPHEN J
IPC: G01N33/543
Filed: 1995-12-13
Granted: 2004-03-16
Abstract: A device and related method for simultaneously performing a plurality of immunoassays to detect the presence of respective analytes in a sample. The device involves the use of a unitary bibulous material providing one or more flow paths having a common origin site and a plurality of respective reagent zones providing the reagents necessary for performing a visual read-out, competitive immunoassay for the presence of the respective analyte.
Patent ES-2135834-T3 (ES)
Inventor: EICKENBERG LEONHARD
IPC: F22B31/00
Filed: 1996-11-16
Granted: 1999-11-01
Abstract: The steam generator has a fluidised bed combustion chamber (1) coupled on the flue gas side to at least one cyclone (5), each followed by a flow bed cooler (12). An immersion head (8) between the cyclone and the latter is coupled to the fluidised combustion chamber via a feedback line. The flow bed cooler, the immersion head and the cyclone are provided as a single unit contained within a common pressure vessel (19).
Patent ES-2180690-T3 (ES)
Inventor: MOO-YOUNG ALFRED
IPC: A61P5/30
Filed: 1991-05-24
Granted: 2003-02-16
Abstract: 16-methylene-17 alpha -acetoxy-19-nopregnene-3,20-dione (ST1435) can be formulated for hormonal therapy by transdermal application to provide sustained blood release through the skin into the blood so as to provide pharmaceutically effective serum levels of ST1435 without occluding the skin.
Patent ES-2147345-T3 (ES)
Inventor: VERWOERD WILLEM TEUNIS
IPC: B29C45/14
Filed: 1996-12-11
Granted: 2000-09-01
Abstract: An apparatus for removing molded products from an injection mold or for placing product parts, such as, for instance, a label, in an injection mold, the apparatus comprising a receiving assembly which comprises at least one receiving element, which receiving element is mounted on a rotary shaft, the apparatus further comprising a first curve mechanism, the movement of the first curve follower thereof relative to the first curve being coupled to the movement of movably arranged mold parts relative to each other, the receiving assembly comprising a receiving assembly body in which the rotary shaft is bearing-mounted for rotation, the receiving assembly body being arranged for movement along a straight guide which extends in a plane extending perpendicularly to the rotary shaft and in a different direction than the main direction, the first curve mechanism constituting a drive of at least the displacement of the receiving assembly body along the straight guide. <IMAGE>
Patent ES-2154397-T3 (ES)
Inventor: MULLER DANIEL
IPC: A61N1/30
Filed: 1996-01-24
Granted: 2001-04-01
Abstract: PCT No. PCT/FR96/00114 Sec. 371 Date Sep. 29, 1997 Sec. 102(e) Date Sep. 29, 1997 PCT Filed Jan. 24, 1996 PCT Pub. No. WO96/22808 PCT Pub. Date Aug. 1, 1996A device comprising a reversible negative electrode in contact with a reservoir element containing an electrolyte which contains an active principle such as an anionic oligosaccharide, particularly a pentasaccharide, in at least partially ionised form, a positive electrode alone or in combination with an electrolyte-containing receptacle, and an electrical signal generator connectable to both electrodes. The generator is arranged to apply electrical signals between the electrodes, which signals have an average voltage such that the average current density generated between the electrodes is 0.05-0.25 mA/cm2. The amount of active principle in the reservoir element combined with the negative electrode is 0.5-12 mg per cm2. The amount of active principle in the reservoir element combined with the negative electrode is 0.5-12 mg per cm2 and per mAh of current through 1 cm2 of the electrode.
Patent ES-2235188-T3 (ES)
Inventor: STERN ROBERT G
IPC: A61B19/00
Filed: 1996-05-21
Granted: 2005-07-01
Abstract: A method for cryogenic treatment of a lesion which includes the steps of delivering a fluorochemical liquid to the lesion, placing at least one cryoprobe into the lesion, and circulating cryogenic fluid through the cryoprobe, the cryogenic fluid causing an ice ball to form in a vicinity around the cryoprobe, wherein the ice ball obliterates at least a portion of the lesion. The fluorochemical liquid is utilized to augment the cryosurgical procedure and is perfused or injected into and/or around the lesioned site prior and/or during the application of a cryoprobe to the site. In one embodiment of the invention, the fluorochemical liquid acts as a contrast agent to enhance real-time medical imaging of the lesioned area and modifies the environment in and around the lesioned area. In another embodiment of the invention, the fluorochemical liquid augments cryosurgical procedures by controlling the size and shape of ice balls formed during the cryosurgical procedures. In this embodiment, a fluorochemical liquid with a properly chosen thermal conductivity and freezing point is utilized. Depending on the thermal properties chosen, the liquid either augments freezing of the target area and/or promotes thermal conduction to freeze larger areas, or limits the freezing of the target area and reduces thermal conduction. In a non-cryoprobe embodiment, the liquid is cooled to a temperature below the freezing point of the biological tissue. The cooled liquid is then infused into or around the cystic lesion to produce ablation.
Patent ES-2154837-T3 (ES)
Title: Procedimiento de generacion de energia e instalacion de central electrica para la ejecucion del procedimiento.
Inventor: TRANKENSCHUH HANS-CHRISTIAN
IPC: F03G6/06
Filed: 1996-10-01
Granted: 2001-04-16
Abstract: EN EL PRESENTE PROCEDIMIENTO PARA GENERAR ENERGIA SE ALIMENTA EL VAPOR HUMEDO, GENERADO EN UNA CENTRAL DE ENERGIA SOLAR (30), A UN CIRCUITO DE VAPOR DE AGUA (8) DE UNA CENTRAL ENERGETICA DE COMBUSTIBLE FOSIL. MEDIANTE ESTA MEDIDA SE EMPLEAN AMPLIAMENTE LOS COMPONENTES DEL CIRCUITO DE VAPOR DE AGUA (8) DE LA CENTRAL ENERGETICA DE COMBUSTIBLE FOSIL Y, CON ELLO, SE REDUCEN LOS COSTES DE TODA LA INSTALACION DE CENTRAL ENERGETICA.
Patent ES-2155207-T3 (ES)
Title: Tapon para una botella que contiene un liquido efervescente.
Inventor: PITOUX JACQUES
IPC: B65D39/12
Filed: 1996-10-31
Granted: 2001-05-01
Abstract: LA INVENCION SE REFIERE A UN DISPOSITIVO ORIGINAL QUE PERMITE TAPAR Y DESTAPAR UNA BOTELLA QUE CONTENGA UN LIQUIDO EFERVESCENTE, COMO EL CHAMPAGNE. EL DISPOSITIVO DE LA INVENCION CONSTA DE MEDIOS (8) QUE PERMITEN VARIAR EL DIAMETRO DEL CUERPO DEL TAPON (3) AL MENOS EN PARTE DE SU ALTURA Y MEDIOS (16, 17) QUE PERMITEN LA EVACUACION DE LOS GASES COMPRIMIDOS SOBRE EL LIQUIDO ENVASADO ANTES DE LA OPERACION DE DESTAPONADO DE LA BOTELLA. ESTOS MEDIOS PARTICULARES PERMITEN EL DESTAPONADO SIN ESFUERZO DE LA BOTELLA Y EVITAN CUALQUIER RIESGO DE SALIDA INCONTROLADA DEL LIQUIDO.
Patent ES-2231830-T3 (ES)
Title: Acondicionador de aire de tipo de montaje en el techo.
Inventor: SAKAINO KAZUAKI
IPC: F24F8/108
Filed: 1997-02-20
Granted: 2005-05-16
Abstract: EN UN APARATO DE AIRE ACONDICIONADO QUE TIENE UN VENTILADOR DE AIRE (7) FIJADO EN LA CARA SUPERIOR (4A), Y UN INTERCAMBIADOR DE CALOR (10) DISPUESTO ALREDEDOR DEL VENTILADOR DE AIRE (7). EL AIRE QUE SE ABSORBE POR EL VENTILADOR DE AIRE (7) ES SOPLADO AL INTERCAMBIADOR DE CALOR (10), UNA PRIMERA PLACA DE INTERCEPCION (100) SE INTERPONE ENTRE LA CARA SUPERIOR (4A) DE LA ESTRUCTURA (4) DEL APARATO DE AIRE ACONDICIONADO Y EL VENTILADOR DE AIRE (7). ADEMAS, UNA BOQUILLA DEL VENTILADOR (13A) ESTA DISPUESTA EN LA PERIFERIA INTERIOR DE LA CUBIERTA (7C) DEL VENTILADOR DE AIRE (7), Y UNA SEGUNDA PLACA DE INTERCEPCION (13) ESTA DISPUESTA EN LA PERIFERIA EXTERIOR DE LA CUBIERTA (7C).